Half-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational study
Academic Article
Publication Date:
2017
abstract:
To investigate the efficacy and safety of fingolimod (FTY) 0.5 mg administered every other day (FTY-EOD) compared to every day (FTY-ED) in multiple sclerosis patients.
Iris type:
1.1 Articolo in rivista
Keywords:
Demyelination; fingolimod; lymphopenia; multiple sclerosis; relapsing-remitting; treatment response
List of contributors:
Zecca, Chiara; Merlini, Arianna; Disanto, Giulio; Rodegher, Mariaemma; Panicari, Letizia; Romeo, Marzia Anita Lucia; Candrian, Ursula; Messina, Maria Josè; Pravatà, Emanuele; Moiola, Lucia; Stefanin, Catia; Ghezzi, Angelo; Perrone, Patrizia; Patti, Francesco; Comi, Giancarlo; Gobbi, Claudio; Martinelli, Vittorio
Published in: